11 billion for a drug in a therapeutic area we have no experience in? Seems desperate.
anonymous Guest anonymous Apr 18, 2023 at 08:46: AM #1 anonymous Guest 11 billion for a drug in a therapeutic area we have no experience in? Seems desperate.
anonymous Guest anonymous Apr 19, 2023 at 11:49: AM #2 anonymous Guest anonymous said: 11 billion for a drug in a therapeutic area we have no experience in? Seems desperate. Click to expand... Its called portfolio diversification...
anonymous said: 11 billion for a drug in a therapeutic area we have no experience in? Seems desperate. Click to expand... Its called portfolio diversification...
anonymous Guest anonymous Apr 20, 2023 at 01:44: PM #3 anonymous Guest Merck drank the Prometheus Kool-Aid and at 200/share they are laughing all the way to the bank.
anonymous Guest anonymous Sep 20, 2023 at 09:05: AM #4 anonymous Guest So what - we are now NOT going to launch this? What happened??!!
anonymous Guest anonymous Sep 20, 2023 at 10:39: AM #5 anonymous Guest anonymous said: So what - we are now NOT going to launch this? What happened??!! Click to expand... What?
anonymous said: So what - we are now NOT going to launch this? What happened??!! Click to expand... What?
